a2 Milk forecasts mid-single-digit FY27 revenue growth and 15% EBITDA margin
The a2 Milk Company says China-label infant formula offtake has recovered to about half of pre-disruption levels, but expects total IMF sales to remain broadly flat in FY27. Group revenue and EBITDA are still forecast to grow, with earnings heavily weighted to the second half.
- China-label IMF offtake recovery to approximately 50% of pre-disruption levels
- FY27 revenue growth forecast in the mid-single-digit percentage range
- Underlying EBITDA margin expected at approximately 15%
- One-off transformation costs of about $15 million in FY27
- First-half revenue and EBITDA expected to decline year on year
Add us as a preferred source on Google
China IMF offtake recovers, but remains well below normal
The a2 Milk Company (NZX:ATM, ASX:A2M) has put a firmer number on its China infant milk formula recovery, reporting estimated China-label offtake at about 50% of pre-supply chain disruption levels. That compares with approximately 40% in August, marking progress but leaving the business only halfway back to its earlier position.
The disruption hit product availability in the fourth quarter of FY26 and prompted many existing users to switch to alternative brands. English-label IMF sales were also indirectly affected by a US-label product recall announced in May. The company says it has launched two new China-label products and an updated a2 Platinum product, while a2 Genesis remains affected by unresolved China importation requirements.
FY27 growth depends on businesses outside infant formula
The update is more upbeat at group level than in the core IMF category. a2 Milk expects FY27 revenue and EBITDA to grow, supported by product innovation, new markets, continued momentum in Other Nutritionals and Liquid Milk, and improving profitability at a2 Pōkeno. Total IMF sales, however, are expected to be broadly similar to FY26.
The company’s latest forecast retains mid-single-digit percentage revenue growth for the year, with an underlying EBITDA margin of approximately 15%. The trajectory will be uneven: first-half revenue is expected to be slightly below the prior corresponding period, while first-half EBITDA is expected to be materially lower. The recovery plan will include increased marketing, particularly in the first half, pushing a larger share of revenue and earnings into the second half. The company’s FY26 results outlook had already described China supply disruption as a drag on profits while retaining a mid-single-digit FY27 revenue-growth expectation.
Transformation costs rise as Pōkeno transition continues
One-off transformation costs are now expected to total about $15 million in FY27, comprising roughly $5 million for a2 Pōkeno integration and about $10 million tied to the supply chain and in-market transition of a2 Platinum. The company says no further transformation costs are expected in FY28.
It also expects depreciation and amortisation of approximately $20 million, cash conversion of 70% to 80% and capital expenditure of about $70 million. The weaker New Zealand dollar is expected to lift reported revenue and expenses, while associated hedge losses are expected to offset the related net earnings uplift.
Recovery rate remains the central swing factor
a2 Milk cautioned that the range of possible FY27 outcomes remains wide. The main variables include the speed and extent of China IMF recovery, competitive intensity, product and supply risks, import requirements, foreign exchange, commodity prices, regulatory changes and geopolitical conditions. The unresolved a2 Genesis importation issue is a specific operational hurdle embedded in the recovery outlook.
Bottom Line?
The headline recovery has improved, but FY27 still rests on a second-half rebound in China IMF and a clean resolution of importation and supply issues.
Questions in the middle?
- Can China-label offtake progress from 50% toward pre-disruption levels quickly enough to support the second-half weighting?
- When will the importation requirements affecting a2 Genesis be resolved?
- Will the $15 million transformation program and $70 million capital expenditure remain within forecast as the Pōkeno transition advances?
Sources
1-
China IMF and FY27 outlook update (opens in a new tab)Official market announcement. The a2 Milk Company Limited · 19 Nov 2026 · thea2milkcompany.com